1	AstraZeneca	astrazeneca	NNP	_	2	nsubj	_
2	has	have	VBZ	_	4	aux	_
3	today	today	NN	_	4	npadvmod	4:AM-TMP
4	rejected	reject	VBD	p2=VBN|pb=reject.01	0	root	_
5	a	a	DT	_	11	det	_
6	'	'	``	_	11	punct	_
7	final	final	JJ	_	11	amod	_
8	'	'	''	_	11	punct	_
9	£69.3billion	£0billion	NN	p2=CD	11	amod	_
10	takeover	takeover	NN	_	11	nn	_
11	bid	bid	NN	p2=VBN	4	dobj	18:A0=PAG;4:A1=PPT
12	from	from	IN	_	11	prep	_
13	US	us	NNP	_	15	nn	_
14	pharmaceutical	pharmaceutical	NN	p2=JJ	15	nn	_
15	giant	giant	NN	p2=JJ	16	nn	_
16	Pfizer	pfizer	NNP	p2=NN	12	pobj	_
17	,	,	,	_	11	punct	_
18	sending	send	VBG	pb=send.01	11	partmod	_
19	its	its	PRP$	_	23	poss	_
20	own	own	JJ	_	23	amod	_
21	share	share	NN	_	22	nn	_
22	price	price	NN	_	23	nn	_
23	plummeting	plummeting	NN	p2=VBG	18	dobj	18:A1=PPT
24	.	.	.	_	4	punct	_

1	The	the	DT	_	3	det	_
2	American	american	JJ	p2=NNP	3	amod	_
3	business	business	NN	_	6	nsubj	6:A0=PAG
4	last	last	JJ	_	5	amod	_
5	night	night	NN	_	6	npadvmod	6:AM-TMP
6	offered	offer	VBD	pb=offer.01	0	root	_
7	the	the	DT	_	8	det	_
8	board	board	NN	_	6	dobj	6:A1=PPT
9	of	of	IN	_	8	prep	_
10	the	the	DT	_	12	det	_
11	British	british	JJ	_	12	amod	_
12	company	company	NN	_	9	pobj	_
13	£55	£0	CD	p2=,	17	hmod	_
14	-	-	HYPH	_	17	hyph	_
15	a	a	DT	_	17	hmod	_
16	-	-	HYPH	_	17	hyph	_
17	share	share	NN	_	19	nsubj	19:A0
18	but	but	CC	_	6	cc	_
19	said	say	VBD	pb=say.01	6	conj	_
20	this	this	DT	_	22	nsubj	22:A1=PPT
21	would	would	MD	_	22	aux	22:AM-MOD
22	be	be	VB	pb=be.01	19	ccomp	19:A1=PPT
23	their	their	PRP$	_	27	poss	_
24	best	good	JJS	p2=RBS	27	amod	_
25	and	and	CC	_	24	cc	_
26	last	last	JJ	p2=RB	27	amod	_
27	offer	offer	NN	_	22	attr	22:A2=PRD
28	.	.	.	_	6	punct	_

1	But	but	CC	_	5	cc	5:AM-DIS
2	AstraZeneca	astrazeneca	NNP	_	5	nsubj	5:A0=PAG;12:A0=PAG
3	has	have	VBZ	_	5	aux	_
4	quickly	quickly	RB	_	5	advmod	5:AM-MNR
5	turned	turn	VBN	p2=VBD|pb=turn.05	29	ccomp	_
6	it	it	PRP	_	5	dobj	5:A1=PPT
7	down	down	RP	_	5	prt	5:C-V
8	,	,	,	_	5	punct	_
9	which	which	WDT	_	12	nsubj	12:R-A0
10	could	could	MD	_	12	aux	12:AM-MOD
11	now	now	RB	_	12	advmod	12:AM-TMP
12	kill	kill	VB	pb=kill.01	5	advcl	_
13	the	the	DT	_	14	det	_
14	deal	deal	NN	_	12	dobj	12:A1=PPT
15	unless	unless	IN	_	18	mark	_
16	they	they	PRP	_	18	nsubjpass	18:A1=PPT
17	are	be	VBP	_	18	auxpass	_
18	offered	offer	VBN	pb=offer.01	12	advcl	_
19	closer	close	RBR	p2=JJR	18	advmod	_
20	to	to	IN	p2=TO	19	prep	_
21	£60	£0	CD	p2=NN	25	hmod	_
22	-	-	HYPH	_	25	hyph	_
23	a	a	DT	p2=JJ	25	hmod	_
24	-	-	HYPH	_	25	hyph	_
25	share	share	NN	_	20	pobj	_
26	,	,	,	_	29	punct	_
27	sources	source	NNS	_	29	nsubj	29:A0
28	have	have	VBP	_	29	aux	_
29	said	say	VBN	p2=VBD|pb=say.01	0	root	_
30	.	.	.	_	29	punct	_

1	The	the	DT	_	2	det	_
2	decision	decision	NN	_	3	nsubj	3:A0=PAG
3	sent	send	VBD	pb=send.02	0	root	_
4	its	its	PRP$	_	5	poss	_
5	shares	share	NNS	_	3	dobj	3:A1=PPT
6	down	down	RB	p2=RP	3	advmod	3:A2=PRD
7	13	0	CD	_	9	num	_
8	per	per	NN	p2=IN	9	nn	_
9	cent	cent	NN	_	6	npadvmod	_
10	when	when	WRB	_	15	advmod	15:R-AM-TMP
11	the	the	DT	_	14	det	_
12	London	london	NNP	_	14	nn	_
13	Stock	stock	NNP	_	14	nn	_
14	Exchange	exchange	NNP	_	15	nsubj	15:A0=PAG
15	opened	open	VBD	pb=open.01	3	advcl	3:AM-TMP
16	this	this	DT	_	17	det	_
17	morning	morning	NN	_	15	npadvmod	15:AM-TMP
18	-	-	:	p2=,	15	punct	_
19	a	a	DT	_	20	det	_
20	drop	drop	NN	_	15	dobj	15:A1=PPT
21	of	of	IN	_	20	prep	_
22	£6	£0	NN	p2=CD	21	pobj	_
23	to	to	TO	p2=IN	24	aux	_
24	£42	£0	VB	p2=CD|pb=£0.01	20	infmod	_
25	each	each	DT	_	24	dobj	24:A1
26	.	.	.	_	3	punct	_

1	Its	its	PRP$	_	3	poss	_
2	market	market	NN	_	3	nn	_
3	value	value	NN	_	4	nsubj	4:A1=PPT
4	is	be	VBZ	pb=be.01	0	root	_
5	now	now	RB	_	4	advmod	4:AM-TMP
6	£52billion	£0billion	CD	p2=NNP	4	attr	4:A2=PRD
7	,	,	,	_	6	punct	_
8	£17billion	£0billion	CD	p2=NNP	9	npadvmod	_
9	less	less	JJR	_	6	amod	_
10	than	than	IN	_	9	prep	_
11	the	the	DT	_	12	det	_
12	value	value	NN	_	10	pobj	15:A1=PPT
13	Pfizer	pfizer	NNP	_	15	nsubj	15:A0=PAG
14	had	have	VBD	_	15	aux	_
15	put	put	VBN	pb=put.01	12	rcmod	_
16	on	on	IN	_	15	prep	15:A2=GOL
17	the	the	DT	_	18	det	_
18	company	company	NN	_	16	pobj	_
19	.	.	.	_	4	punct	_

1	AstraZeneca	astrazeneca	NNP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	today	today	NN	_	2	npadvmod	2:AM-TMP
4	the	the	DT	_	6	det	_
5	proposed	propose	VBN	p2=JJ|pb=propose.01	6	amod	_
6	deal	deal	NN	_	8	nsubj	8:A0=PAG;5:A1=PPT
7	would	would	MD	_	8	aux	8:AM-MOD
8	bring	bring	VB	pb=bring.01	2	ccomp	2:A1=PPT
9	'	'	``	p2=''	8	punct	_
10	uncertainty	uncertainty	NN	_	8	dobj	8:A1=PPT
11	and	and	CC	_	10	cc	_
12	risk	risk	NN	p2=VB	10	conj	_
13	'	'	''	p2=,	12	punct	_
14	for	for	IN	_	10	prep	_
15	its	its	PRP$	_	16	poss	_
16	shareholders	shareholder	NNS	_	14	pobj	_
17	and	and	CC	_	10	cc	_
18	'	'	``	p2=''	19	punct	_
19	undervalues	undervalues	NNS	p2=IN	10	conj	_
20	the	the	DT	_	21	det	_
21	company	company	NN	_	10	conj	_
22	and	and	CC	_	21	cc	_
23	its	its	PRP$	_	25	poss	_
24	attractive	attractive	JJ	_	25	amod	_
25	prospects	prospect	NNS	_	21	conj	_
26	'	'	''	p2=POS	8	punct	_
27	.	.	.	_	2	punct	_

1	He	he	PRP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	that	that	IN	_	16	complm	_
4	from	from	IN	_	16	prep	16:AM-TMP
5	the	the	DT	_	6	det	_
6	time	time	NN	_	4	pobj	_
7	of	of	IN	_	6	prep	_
8	initial	initial	JJ	_	9	amod	_
9	talks	talk	NNS	_	7	pobj	_
10	in	in	IN	_	9	prep	_
11	January	january	NNP	_	10	pobj	_
12	,	,	,	_	16	punct	_
13	the	the	DT	_	15	det	_
14	US	us	NNP	_	15	nn	_
15	company	company	NN	_	16	nsubj	16:A0=PAG
16	had	have	VBD	pb=have.03	2	ccomp	2:A1=PPT
17	'	'	``	p2=''	16	punct	_
18	failed	fail	VBD	p2=VBN|pb=fail.01	16	ccomp	16:A1=PPT
19	to	to	TO	_	20	aux	_
20	make	make	VB	pb=make.02	18	xcomp	18:A2=PPT
21	a	a	DT	_	28	det	_
22	compelling	compelling	JJ	_	28	amod	_
23	strategic	strategic	JJ	_	28	amod	_
24	,	,	,	_	28	punct	_
25	business	business	NN	_	28	nn	_
26	or	or	CC	_	25	cc	_
27	value	value	NN	_	25	conj	_
28	case	case	NN	_	20	dobj	20:A1=PRD
29	'	'	''	_	16	punct	_
30	.	.	.	_	2	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	it	it	PRP	_	6	nsubj	6:A0=PAG
4	would	would	MD	_	6	aux	6:AM-MOD
5	only	only	RB	_	6	advmod	6:AM-ADV
6	proceed	proceed	VB	pb=proceed.01	2	ccomp	2:A1=PPT
7	with	with	IN	_	6	prep	6:A1=PPT
8	the	the	DT	_	9	det	_
9	takeover	takeover	NN	_	7	pobj	_
10	if	if	IN	_	12	mark	_
11	it	it	PRP	_	12	nsubj	12:A0=PAG
12	received	receive	VBD	pb=receive.01	6	advcl	6:AM-ADV
13	the	the	DT	_	14	det	_
14	support	support	NN	_	12	dobj	12:A1=PPT
15	of	of	IN	_	14	prep	_
16	the	the	DT	_	18	det	_
17	AstraZeneca	astrazeneca	NNP	_	18	nn	_
18	board	board	NN	_	15	pobj	23:A1=PPT
19	who	who	WP	_	23	nsubj	23:R-A1
20	have	have	VBP	_	23	aux	_
21	so	so	RB	p2=IN	22	advmod	_
22	far	far	RB	_	23	advmod	23:AM-TMP
23	been	be	VBN	pb=be.01	18	rcmod	_
24	hostile	hostile	JJ	_	23	acomp	23:A2=PRD
25	to	to	IN	_	24	prep	_
26	the	the	DT	_	27	det	_
27	bid	bid	NN	_	25	pobj	_
28	.	.	.	_	2	punct	_

1	AstraZenica	astrazenica	NNP	_	3	nsubj	3:A0=PAG;12:A0=PAG
2	previously	previously	RB	_	3	advmod	3:AM-TMP
3	rejected	reject	VBD	pb=reject.01	0	root	_
4	an	an	DT	_	5	det	_
5	offer	offer	NN	p2=VBP	3	dobj	3:A1=PPT
6	worth	worth	JJ	p2=NN	5	amod	_
7	£50	£0	CD	p2=,	11	hmod	_
8	-	-	HYPH	_	11	hyph	_
9	a	a	DT	_	11	hmod	_
10	-	-	HYPH	p2=:	11	hyph	_
11	share	share	NN	_	6	npadvmod	_
12	claiming	claim	VBG	p2=NN|pb=claim.01	3	advcl	_
13	it	it	PRP	_	14	nsubj	14:A0=PAG
14	undervalued	undervalue	VBD	p2=VBN|pb=undervalue.01	12	ccomp	12:A1=PPT
15	the	the	DT	_	16	det	_
16	company	company	NN	_	14	dobj	14:A1=PPT
17	.	.	.	_	3	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0
2	has	have	VBZ	_	3	aux	_
3	said	say	VBN	pb=say.01	0	root	_
4	if	if	IN	_	7	mark	_
5	the	the	DT	_	6	det	_
6	deal	deal	NN	_	7	nsubj	7:A1=PPT
7	is	be	VBZ	pb=be.01	12	advcl	12:AM-ADV;26:AM-ADV
8	successful	successful	JJ	_	7	acomp	7:A2=PRD
9	,	,	,	_	12	punct	_
10	it	it	PRP	_	12	nsubj	12:A0=PAG
11	will	will	MD	_	12	aux	12:AM-MOD
12	create	create	VB	pb=create.01	3	ccomp	3:A1=PPT
13	the	the	DT	_	14	det	_
14	world	world	NN	_	18	poss	_
15	's	's	POS	_	14	possessive	_
16	largest	large	JJS	_	18	amod	_
17	pharmaceutical	pharmaceutical	JJ	p2=NN	18	amod	_
18	company	company	NN	_	12	dobj	12:A1=PPT
19	with	with	IN	_	18	prep	_
20	a	a	DT	_	21	det	_
21	headquarters	headquarters	NN	_	19	pobj	_
22	in	in	IN	_	21	prep	_
23	New	new	NNP	_	24	nn	_
24	York	york	NNP	_	22	pobj	_
25	but	but	CC	p2=RB	12	cc	_
26	based	base	VBN	pb=base.02	12	conj	_
27	for	for	IN	_	26	prep	26:A2=DIR
28	tax	tax	NN	_	29	nn	_
29	reasons	reason	NNS	_	27	pobj	_
30	in	in	IN	_	29	prep	_
31	Britain	britain	NNP	_	30	pobj	_
32	.	.	.	_	3	punct	_

1	AstraZeneca	astrazeneca	NNP	_	3	nsubj	3:A0=PAG;13:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	laid	lay	VBN	pb=lay.01	0	root	_
4	out	out	RP	_	3	prt	3:C-V
5	details	detail	NNS	_	3	dobj	3:A1=PPT
6	of	of	IN	_	5	prep	_
7	its	its	PRP$	_	8	poss	_
8	pipeline	pipeline	NN	_	6	pobj	_
9	of	of	IN	_	8	prep	_
10	new	new	JJ	_	11	amod	_
11	drugs	drug	NNS	_	9	pobj	_
12	and	and	CC	_	3	cc	_
13	argues	argue	VBZ	p2=NNS|pb=argue.01	3	conj	_
14	there	there	EX	_	15	expl	_
15	is	be	VBZ	pb=be.02	13	ccomp	13:A1=PPT
16	no	no	DT	_	17	det	_
17	inevitability	inevitability	NN	_	15	attr	15:A1=PPT
18	about	about	IN	_	17	prep	_
19	a	a	DT	_	21	det	_
20	Pfizer	pfizer	NNP	_	21	nn	_
21	deal	deal	NN	_	18	pobj	_
22	,	,	,	_	15	punct	_
23	although	although	IN	_	27	mark	_
24	its	its	PRP$	_	25	poss	_
25	management	management	NN	_	27	nsubj	27:A0=PAG
26	also	also	RB	_	27	advmod	27:AM-ADV
27	acknowledges	acknowledge	VBZ	pb=acknowledge.01	15	advcl	15:AM-ADV
28	the	the	DT	_	29	det	_
29	board	board	NN	_	31	nsubj	33:A0=PAG
30	would	would	MD	_	31	aux	31:AM-MOD
31	have	have	VB	pb=have.02	27	ccomp	27:A1=PPT
32	to	to	TO	_	33	aux	_
33	consider	consider	VB	pb=consider.01	31	xcomp	_
34	a	a	DT	_	36	det	_
35	compelling	compelling	JJ	_	36	amod	_
36	bid	bid	NN	_	33	dobj	33:A1
37	.	.	.	_	3	punct	_

1	There	there	EX	_	3	expl	_
2	has	have	VBZ	_	3	aux	_
3	been	be	VBN	pb=be.02	0	root	_
4	a	a	DT	_	7	det	_
5	mounting	mount	VBG	p2=JJ|pb=mount.02	7	amod	_
6	political	political	JJ	_	7	amod	_
7	backlash	backlash	NN	_	3	attr	3:A1=PPT;5:A1=PPT
8	against	against	IN	_	7	prep	_
9	the	the	DT	_	11	det	_
10	proposed	propose	VBN	p2=JJ|pb=propose.01	11	amod	_
11	deal	deal	NN	_	8	pobj	10:A1=PPT
12	in	in	IN	_	11	prep	_
13	Britain	britain	NNP	_	12	pobj	_
14	,	,	,	_	13	punct	_
15	the	the	DT	_	17	det	_
16	United	united	NNP	_	17	nn	_
17	States	states	NNP	_	13	conj	_
18	and	and	CC	_	17	cc	_
19	Sweden	sweden	NNP	_	17	conj	_
20	,	,	,	_	17	punct	_
21	where	where	WRB	_	23	advmod	23:R-AM-LOC
22	AstraZeneca	astrazeneca	NNP	_	23	nsubj	23:A0=PAG
23	has	have	VBZ	pb=have.03	17	rcmod	_
24	half	half	PDT	p2=VBN	26	predet	_
25	its	its	PRP$	_	26	poss	_
26	roots	root	NNS	_	23	dobj	23:A1=PPT
27	.	.	.	_	3	punct	_

1	The	the	DT	_	3	det	_
2	Swedish	swedish	JJ	_	3	amod	_
3	government	government	NN	_	4	nsubj	4:A0=PAG
4	launched	launch	VBD	pb=launch.01	0	root	_
5	a	a	DT	_	7	det	_
6	concerted	concerted	JJ	_	7	amod	_
7	effort	effort	NN	_	4	dobj	4:A1=PPT
8	on	on	IN	_	4	prep	4:AM-TMP
9	Friday	friday	NNP	_	8	pobj	_
10	against	against	IN	_	4	prep	_
11	a	a	DT	_	12	det	_
12	merger	merger	NN	_	10	pobj	16:A0=PAG
13	it	it	PRP	_	14	nsubj	14:A0=PPT
14	fears	fear	VBZ	pb=fear.01	12	rcmod	_
15	will	will	MD	_	16	aux	16:AM-MOD
16	lead	lead	VB	pb=lead.03	14	ccomp	14:A1=PAG
17	to	to	IN	_	16	prep	16:A2=PRD
18	cuts	cut	NNS	_	17	pobj	_
19	in	in	IN	_	18	prep	_
20	science	science	NN	_	21	nn	_
21	jobs	job	NNS	_	19	pobj	_
22	and	and	CC	_	21	cc	_
23	research	research	NN	_	21	conj	_
24	,	,	,	_	18	punct	_
25	echoing	echo	VBG	pb=echo.01	26	amod	_
26	concerns	concern	NNS	_	18	conj	25:A0=PPT;27:A1=PPT
27	aired	air	VBN	pb=air.01	26	partmod	_
28	by	by	IN	_	27	agent	27:A0=PAG
29	British	british	JJ	_	30	amod	_
30	lawmakers	lawmaker	NNS	_	28	pobj	_
31	at	at	IN	_	27	prep	27:AM-LOC
32	two	#crd#	CD	_	34	num	_
33	parliamentary	parliamentary	JJ	_	34	amod	_
34	hearings	hearing	NNS	_	31	pobj	_
35	last	last	JJ	p2=VBP	36	amod	_
36	week	week	NN	_	27	npadvmod	27:AM-TMP
37	and	and	CC	_	26	cc	_
38	fears	fear	NNS	p2=VBZ	26	conj	_
39	for	for	IN	_	38	prep	_
40	US	us	NNP	_	41	nn	_
41	jobs	job	NNS	_	39	pobj	_
42	in	in	IN	_	41	prep	_
43	states	state	NNS	_	42	pobj	46:AM-LOC
44	where	where	WRB	_	46	advmod	46:R-AM-LOC
45	AstraZeneca	astrazeneca	NNP	_	46	nsubj	46:A0=PAG
46	has	have	VBZ	pb=have.03	43	rcmod	_
47	a	a	DT	_	49	det	_
48	large	large	JJ	_	49	amod	_
49	presence	presence	NN	_	46	dobj	46:A1=PPT
50	.	.	.	_	4	punct	_

1	It	it	PRP	_	2	nsubj	2:A1=PPT
2	came	come	VBD	pb=come.04	0	root	_
3	after	after	IN	_	2	prep	2:AM-TMP
4	a	a	DT	_	5	det	_
5	weekend	weekend	NN	_	3	pobj	_
6	of	of	IN	_	5	prep	_
7	talks	talk	NNS	_	6	pobj	8:A2=PPT
8	involving	involve	VBG	pb=involve.01	7	partmod	_
9	Mr	mr	NNP	_	10	nn	_
10	Johannson	johannson	NNP	_	8	dobj	8:A1=PPT
11	,	,	,	_	10	punct	_
12	his	his	PRP$	_	14	poss	_
13	chief	chief	JJ	p2=NN	14	amod	_
14	executive	executive	NN	_	16	nn	_
15	Pascal	pascal	NNP	_	16	nn	_
16	Soriot	soriot	NNP	p2=VBD	10	conj	_
17	and	and	CC	_	16	cc	_
18	finance	finance	NN	p2=VB	19	nn	_
19	director	director	NN	_	21	nn	_
20	Marc	marc	NNP	_	21	nn	_
21	Dunoyer	dunoyer	NNP	_	16	conj	_
22	after	after	IN	_	24	mark	_
23	Pfizer	pfizer	NNP	_	24	nsubj	24:A0
24	made	make	VBD	pb=make.LV	2	advcl	2:AM-TMP
25	an	an	DT	_	26	det	_
26	offer	offer	NN	_	24	dobj	24:AM-PRR
27	of	of	IN	_	26	prep	_
28	£53.50	£0	CD	p2=,	27	pobj	_
29	a	a	DT	_	30	det	_
30	share	share	NN	_	28	npadvmod	_
31	for	for	IN	_	26	prep	_
32	the	the	DT	_	36	det	_
33	UK	uk	NNP	_	35	hmod	_
34	-	-	HYPH	_	35	hyph	_
35	based	base	VBN	_	36	amod	_
36	group	group	NN	_	31	pobj	_
37	.	.	.	_	2	punct	_

1	This	this	DT	_	3	nsubjpass	3:A1=PPT;14:A1=PPT
2	was	be	VBD	_	3	auxpass	_
3	increased	increase	VBN	p2=JJ|pb=increase.01	0	root	_
4	to	to	TO	p2=IN	5	aux	_
5	£55	£0	VB	pb=£0.01	3	advcl	3:AM-PRP
6	a	a	DT	_	7	det	_
7	share	share	NN	_	5	dobj	5:A1
8	by	by	IN	_	5	prep	5:AM-TMP
9	Sunday	sunday	NNP	_	10	nn	_
10	evening	evening	NN	_	8	pobj	_
11	but	but	CC	_	3	cc	_
12	was	be	VBD	_	14	auxpass	_
13	again	again	RB	_	14	advmod	14:AM-TMP
14	rejected	reject	VBN	p2=VBD|pb=reject.01	3	conj	_
15	today	today	NN	_	14	npadvmod	14:AM-TMP
16	.	.	.	_	3	punct	_

1	Mr	mr	NNP	_	2	nn	_
2	Johansson	johansson	NNP	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	0	root	_
4	that	that	IN	_	14	complm	_
5	in	in	IN	_	14	prep	14:AM-ADV
6	response	response	NN	_	5	pobj	_
7	to	to	IN	_	6	prep	_
8	the	the	DT	_	10	det	_
9	Friday	friday	NNP	_	10	nn	_
10	offer	offer	NN	p2=VBP	7	pobj	_
11	,	,	,	_	14	punct	_
12	it	it	PRP	_	14	nsubj	14:A0=CAU
13	had	have	VBD	_	14	aux	_
14	indicated	indicate	VBN	pb=indicate.01	3	ccomp	3:A1=PPT
15	that	that	IN	_	18	complm	_
16	'	'	``	p2=''	18	punct	_
17	even	even	RB	_	18	advmod	18:AM-ADV
18	assuming	assume	VBG	pb=assume.02	14	ccomp	14:A1=PPT
19	that	that	IN	p2=DT	27	complm	_
20	other	other	JJ	_	22	amod	_
21	key	key	JJ	_	22	amod	_
22	aspects	aspect	NNS	_	27	nsubj	27:A1=PPT
23	of	of	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	proposal	proposal	NN	_	23	pobj	_
26	had	have	VBD	_	27	aux	_
27	been	be	VBN	pb=be.01	18	ccomp	18:A1=PPT
28	satisfactory	satisfactory	JJ	_	27	acomp	27:A2=PRD
29	'	'	''	p2=``	27	punct	_
30	that	that	IN	p2=WDT	45	complm	_
31	the	the	DT	_	32	det	_
32	price	price	NN	_	45	nsubj	45:A1=PPT;41:A3=PRD
33	at	at	IN	_	39	prep	_
34	which	which	WDT	_	33	pobj	_
35	it	it	PRP	_	39	nsubjpass	41:A0=PAG;39:A1=PPT
36	would	would	MD	_	39	aux	39:AM-MOD
37	have	have	VB	_	39	aux	_
38	been	be	VBN	_	39	auxpass	_
39	prepared	prepare	VBN	p2=JJ|pb=prepare.02	32	rcmod	_
40	to	to	TO	_	41	aux	_
41	recommend	recommend	VB	pb=recommend.01	39	xcomp	39:A2=PRP
42	a	a	DT	_	43	det	_
43	sale	sale	NN	_	41	dobj	41:A1=PPT
44	would	would	MD	_	45	aux	45:AM-MOD
45	be	be	VB	pb=be.01	27	ccomp	_
46	more	more	JJR	_	48	amod	_
47	than	than	IN	_	48	quantmod	_
48	10	0	CD	_	50	num	_
49	per	per	NN	p2=IN	50	nn	_
50	cent	cent	NN	_	51	npadvmod	_
51	higher	high	JJR	p2=RBR	45	acomp	45:A2=PRD
52	.	.	.	_	3	punct	_

1	He	he	PRP	_	2	nsubj	2:A0=PAG
2	added	add	VBD	p2=VBN|pb=add.01	0	root	_
3	:	:	:	_	2	punct	_
4	'	'	''	p2=``	2	punct	_
5	The	the	DT	_	7	det	_
6	final	final	JJ	_	7	amod	_
7	proposal	proposal	NN	_	8	nsubj	8:A1=PPT
8	is	be	VBZ	pb=be.01	2	ccomp	2:A1=PPT
9	a	a	DT	_	11	det	_
10	minor	minor	JJ	_	11	amod	_
11	improvement	improvement	NN	_	8	attr	13:A0;15:A1=PPT;27:A1=PPT;8:A2=PRD
12	which	which	WDT	_	13	nsubj	13:R-A0;15:R-A1;27:R-A1
13	continues	continue	VBZ	pb=continue.01	11	rcmod	_
14	to	to	TO	_	15	aux	_
15	fall	fall	VB	pb=fall.01	13	xcomp	13:A1=PPT
16	short	short	RB	p2=JJ	15	advmod	15:A4=GOL
17	of	of	IN	_	16	prep	_
18	the	the	DT	_	19	det	_
19	board	board	NN	_	21	poss	_
20	's	's	POS	_	19	possessive	_
21	view	view	NN	_	17	pobj	_
22	of	of	IN	_	21	prep	_
23	value	value	NN	_	22	pobj	_
24	and	and	CC	_	13	cc	_
25	has	have	VBZ	_	27	aux	_
26	been	be	VBN	_	27	auxpass	_
27	rejected	reject	VBN	pb=reject.01	13	conj	_
28	.	.	.	_	2	punct	_

1	'	'	''	p2=POS	4	punct	_
2	Mr	mr	NNP	_	3	nn	_
3	Johansson	johansson	NNP	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	Astra	astra	NNP	_	7	nsubj	7:A0=PAG
6	had	have	VBD	_	7	aux	_
7	created	create	VBN	pb=create.01	4	ccomp	4:A1=PPT
8	a	a	DT	_	10	det	_
9	'	'	``	p2=''	10	punct	_
10	culture	culture	NN	_	7	dobj	7:A1=PPT
11	of	of	IN	_	10	prep	_
12	innovation	innovation	NN	_	11	pobj	_
13	,	,	,	_	10	punct	_
14	with	with	IN	_	4	prep	_
15	science	science	NN	_	14	pobj	_
16	at	at	IN	_	15	prep	_
17	the	the	DT	_	18	det	_
18	heart	heart	NN	_	16	pobj	_
19	of	of	IN	_	18	prep	_
20	its	its	PRP$	_	21	poss	_
21	operations	operation	NNS	_	19	pobj	_
22	'	'	''	p2=POS	10	punct	_
23	.	.	.	_	4	punct	_

1	He	he	PRP	_	2	nsubj	2:A0=PAG
2	reiterated	reiterate	VBD	pb=reiterate.01	0	root	_
3	widely	widely	RB	_	4	advmod	4:AM-MNR
4	expressed	express	VBN	p2=VBD|pb=express.01	5	amod	_
5	concerns	concern	NNS	_	2	dobj	2:A1=PPT;4:A1=PPT
6	that	that	IN	_	10	complm	_
7	a	a	DT	_	8	det	_
8	deal	deal	NN	_	10	nsubj	10:A0=PAG
9	would	would	MD	_	10	aux	10:AM-MOD
10	have	have	VB	pb=have.03	5	ccomp	_
11	'	'	``	p2=VBN	13	punct	_
12	serious	serious	JJ	_	13	amod	_
13	consequences	consequence	NNS	_	10	dobj	10:A1=PPT
14	for	for	IN	_	13	prep	_
15	the	the	DT	_	16	det	_
16	company	company	NN	_	14	pobj	_
17	,	,	,	_	16	punct	_
18	our	our	PRP$	_	19	poss	_
19	employees	employee	NNS	_	16	conj	_
20	and	and	CC	_	19	cc	_
21	the	the	DT	_	24	det	_
22	life	life	NN	_	24	nn	_
23	sciences	science	NNS	_	24	nn	_
24	sector	sector	NN	p2=VBP	19	conj	_
25	in	in	IN	_	24	prep	_
26	the	the	DT	_	27	det	_
27	UK	uk	NNP	_	25	pobj	_
28	,	,	,	_	27	punct	_
29	Sweden	sweden	NNP	_	27	conj	_
30	and	and	CC	_	29	cc	_
31	the	the	DT	_	32	det	_
32	US	us	NNP	_	29	conj	_
33	'	'	''	p2=POS	24	punct	_
34	.	.	.	_	2	punct	_

1	Astra	astra	NNP	p2=NN	2	nsubj	2:A0=PAG
2	outlined	outline	VBD	pb=outline.01	0	root	_
3	four	#crd#	CD	_	5	num	_
4	key	key	JJ	p2=NN	5	amod	_
5	points	point	NNS	_	2	dobj	6:A0=PPT;2:A1=PPT
6	underlying	underlie	VBG	pb=underlie.01	5	partmod	_
7	its	its	PRP$	_	8	poss	_
8	rejection	rejection	NN	_	6	dobj	6:A1=PPT
9	of	of	IN	_	8	prep	_
10	the	the	DT	_	11	det	_
11	deal	deal	NN	_	9	pobj	_
12	,	,	,	_	5	punct	_
13	starting	start	VBG	pb=start.01	5	partmod	_
14	with	with	IN	_	13	prep	13:A2=MNR
15	planned	plan	VBN	p2=JJ|pb=plan.01	18	amod	_
16	cost	cost	NN	_	18	hmod	_
17	-	-	HYPH	p2=,	18	hyph	_
18	cutting	cutting	NN	p2=VBG	14	pobj	22:A0;15:A1=PPT
19	which	which	WDT	_	22	nsubj	22:R-A0
20	would	would	MD	_	22	aux	22:AM-MOD
21	'	'	``	p2=''	22	punct	_
22	imply	imply	VB	pb=imply.01	18	rcmod	_
23	a	a	DT	_	25	det	_
24	meaningful	meaningful	JJ	_	25	amod	_
25	reduction	reduction	NN	_	22	dobj	22:A1=PPT
26	in	in	IN	_	25	prep	_
27	research	research	NN	_	26	pobj	_
28	and	and	CC	_	27	cc	_
29	development	development	NN	_	27	conj	_
30	potential	potential	NN	p2=JJ	27	conj	_
31	and	and	CC	_	30	cc	_
32	capabilities	capability	NNS	_	30	conj	_
33	'	'	''	p2=POS	25	punct	_
34	.	.	.	_	2	punct	_

1	It	it	PRP	_	3	nsubj	3:A0
2	also	also	RB	_	3	advmod	3:AM-DIS
3	said	say	VBD	pb=say.01	0	root	_
4	the	the	DT	_	5	det	_
5	integration	integration	NN	_	11	nsubj	11:A0=PAG
6	of	of	IN	_	5	prep	_
7	the	the	DT	_	9	det	_
8	two	#crd#	CD	_	9	num	_
9	companies	company	NNS	_	6	pobj	_
10	would	would	MD	_	11	aux	11:AM-MOD
11	risk	risk	VB	pb=risk.01	3	ccomp	3:A1=PPT
12	'	'	``	_	11	punct	_
13	significant	significant	JJ	_	14	amod	_
14	disruption	disruption	NN	_	11	dobj	11:A1=PPT
15	'	'	''	_	11	punct	_
16	to	to	IN	_	11	prep	_
17	the	the	DT	_	18	det	_
18	delivery	delivery	NN	_	16	pobj	_
19	of	of	IN	_	18	prep	_
20	its	its	PRP$	_	28	poss	_
21	new	new	JJ	_	28	amod	_
22	drugs	drug	NNS	_	24	hmod	_
23	-	-	HYPH	p2=,	24	hyph	_
24	echoing	echo	VBG	_	28	amod	_
25	Mr	mr	NNP	_	26	nn	_
26	Soriot	soriot	NNP	_	28	poss	_
27	's	's	POS	_	26	possessive	_
28	claim	claim	NN	_	19	pobj	_
29	before	before	IN	p2=RB	28	prep	_
30	MPs	mps	NNP	p2=NNS	29	pobj	_
31	last	last	JJ	_	32	amod	_
32	week	week	NN	_	28	npadvmod	_
33	that	that	IN	_	40	complm	_
34	life	life	NN	_	36	hmod	_
35	-	-	HYPH	_	36	hyph	_
36	saving	save	VBG	_	37	amod	_
37	medicines	medicine	NNS	_	40	nsubjpass	40:A1=PPT
38	could	could	MD	_	40	aux	40:AM-MOD
39	be	be	VB	_	40	auxpass	_
40	delayed	delay	VBN	pb=delay.01	11	ccomp	_
41	by	by	IN	_	40	agent	40:A0=PAG
42	the	the	DT	_	43	det	_
43	distraction	distraction	NN	_	41	pobj	44:A1=PPT
44	caused	cause	VBN	pb=cause.01	43	partmod	_
45	by	by	IN	_	44	agent	44:A0=CAU
46	a	a	DT	_	49	det	_
47	mega	mega	JJ	_	49	hmod	_
48	-	-	HYPH	_	49	hyph	_
49	merger	merger	NN	_	45	pobj	_
50	.	.	.	_	3	punct	_

1	The	the	DT	_	3	det	_
2	UK	uk	NNP	_	3	nn	_
3	firm	firm	NN	_	4	nsubj	4:A0=PAG;13:A0
4	pointed	point	VBD	pb=point.01	0	root	_
5	as	as	RB	_	6	advmod	_
6	well	well	RB	_	4	advmod	4:AM-DIS
7	to	to	IN	_	4	prep	4:A2=GOL
8	Pfizer	pfizer	NNP	_	11	poss	_
9	's	's	POS	_	8	possessive	_
10	past	past	JJ	p2=NN	11	nn	_
11	record	record	NN	_	7	pobj	_
12	,	,	,	_	4	punct	_
13	saying	say	VBG	pb=say.01	4	advcl	4:AM-ADV
14	its	its	PRP$	_	19	poss	_
15	previous	previous	JJ	_	19	amod	_
16	large	large	JJ	p2=NN	18	hmod	_
17	-	-	HYPH	_	18	hyph	_
18	scale	scale	NN	_	19	nn	_
19	takeovers	takeover	NNS	_	21	nsubj	_
20	had	have	VBD	_	21	aux	_
21	'	'	VBN	p2=''	22	auxpass	_
22	highlighted	highlight	VBN	p2=VBD|pb=highlight.01	13	ccomp	13:A1=PPT
23	the	the	DT	_	24	det	_
24	challenges	challenge	NNS	_	22	dobj	22:A1=PPT
25	around	around	IN	_	24	prep	_
26	the	the	DT	_	28	det	_
27	negative	negative	JJ	_	28	amod	_
28	impact	impact	NN	_	25	pobj	_
29	of	of	IN	_	28	prep	_
30	integration	integration	NN	_	29	pobj	_
31	on	on	IN	_	28	prep	_
32	research	research	NN	_	31	pobj	_
33	and	and	CC	_	32	cc	_
34	development	development	NN	_	32	conj	_
35	productivity	productivity	NN	_	32	conj	_
36	and	and	CC	_	35	cc	_
37	output	output	NN	_	35	conj	_
38	'	'	''	_	37	punct	_
39	.	.	.	_	4	punct	_

1	Finally	finally	RB	_	4	advmod	4:AM-TMP
2	,	,	,	_	4	punct	_
3	Astra	astra	NNP	_	4	nsubj	4:A0=PAG
4	expressed	express	VBD	pb=express.01	0	root	_
5	concerns	concern	NNS	_	4	dobj	4:A1=PPT
6	about	about	IN	_	5	prep	_
7	the	the	DT	_	8	det	_
8	impact	impact	NN	_	6	pobj	_
9	of	of	IN	_	8	prep	_
10	plans	plan	NNS	_	9	pobj	_
11	by	by	IN	_	10	prep	_
12	the	the	DT	_	14	det	_
13	US	us	NNP	_	14	nn	_
14	firm	firm	NN	p2=VB	11	pobj	_
15	to	to	TO	_	16	aux	_
16	separate	separate	VB	pb=separate.01	10	infmod	_
17	out	out	RP	_	16	prt	16:C-V
18	its	its	PRP$	_	19	poss	_
19	operations	operation	NNS	_	16	dobj	16:A1=PPT
20	into	into	IN	_	16	prep	16:A2=DIR
21	three	#crd#	CD	_	23	num	_
22	business	business	NN	_	23	nn	_
23	units	unit	NNS	_	20	pobj	_
24	.	.	.	_	4	punct	_

1	In	in	IN	_	7	prep	7:AM-DIS
2	addition	addition	NN	_	1	pobj	_
3	,	,	,	_	7	punct	_
4	the	the	DT	_	6	det	_
5	rejection	rejection	NN	_	6	nn	_
6	statement	statement	NN	_	7	nsubj	7:A0=PAG
7	repeated	repeat	VBD	p2=VBN|pb=repeat.01	0	root	_
8	the	the	DT	_	9	det	_
9	concern	concern	NN	_	7	dobj	7:A1=PPT;10:A1=PPT
10	expressed	express	VBD	p2=VBN|pb=express.01	9	partmod	_
11	about	about	IN	_	10	prep	_
12	the	the	DT	_	18	det	_
13	'	'	``	_	18	punct	_
14	tax	tax	NN	_	16	hmod	_
15	-	-	HYPH	_	16	hyph	_
16	driven	drive	VBN	_	17	amod	_
17	inversion	inversion	NN	_	18	nn	_
18	structure	structure	NN	_	11	pobj	_
19	'	'	''	p2=NN	18	punct	_
20	of	of	IN	_	18	prep	_
21	the	the	DT	_	22	det	_
22	deal	deal	NN	_	20	pobj	_
23	.	.	.	_	7	punct	_

1	This	this	DT	_	2	nsubj	2:A0=PAG
2	refers	refer	VBZ	pb=refer.01	0	root	_
3	to	to	IN	_	2	prep	2:A1=PPT
4	the	the	DT	_	6	det	_
5	controversial	controversial	JJ	_	6	amod	_
6	proposal	proposal	NN	_	3	pobj	_
7	to	to	TO	_	8	aux	_
8	re-domicile	re-domicile	VB	pb=re-domicile.01	6	infmod	_
9	the	the	DT	_	12	det	_
10	newly	newly	RB	_	11	advmod	11:AM-TMP
11	merged	merge	VBN	p2=VBD|pb=merge.01	12	amod	_
12	giant	giant	NN	p2=JJ	8	dobj	8:A1;11:A1=PPT
13	to	to	IN	_	8	prep	8:A2
14	the	the	DT	_	15	det	_
15	UK	uk	NNP	_	13	pobj	_
16	for	for	IN	_	8	prep	8:AM-PNC
17	tax	tax	NN	_	18	nn	_
18	purposes	purpose	NNS	_	16	pobj	_
19	while	while	IN	_	20	mark	_
20	maintaining	maintain	VBG	pb=maintain.01	8	advcl	_
21	corporate	corporate	JJ	_	22	amod	_
22	headquarters	headquarter	NNS	p2=NN	20	dobj	20:A1=PPT
23	in	in	IN	_	20	prep	20:AM-LOC
24	the	the	DT	_	25	det	_
25	US	us	NNP	_	23	pobj	_
26	and	and	CC	_	25	cc	_
27	a	a	DT	p2=XX	28	det	_
28	listing	listing	NN	p2=VBG	25	conj	_
29	on	on	IN	_	28	prep	_
30	the	the	DT	_	34	det	_
31	New	new	NNP	_	32	nn	_
32	York	york	NNP	_	34	nn	_
33	Stock	stock	NNP	_	34	nn	_
34	Exchange	exchange	NNP	_	29	pobj	_
35	.	.	.	_	2	punct	_

1	Astra	astra	NNP	_	2	nsubj	2:A0=PAG
2	noted	note	VBD	pb=note.01	0	root	_
3	in	in	IN	_	2	prep	2:AM-LOC
4	its	its	PRP$	_	5	poss	_
5	statement	statement	NN	_	3	pobj	_
6	that	that	IN	_	11	complm	_
7	this	this	DT	_	11	nsubj	22:A0=PAG;11:A1=PPT
8	had	have	VBD	p2=NN	11	aux	_
9	'	'	``	p2=''	11	punct	_
10	already	already	RB	_	11	advmod	11:AM-TMP
11	been	be	VBN	pb=be.01	2	ccomp	2:A1=PPT
12	the	the	DT	_	13	det	_
13	subject	subject	NN	_	11	attr	11:A2=PRD
14	of	of	IN	_	13	prep	_
15	intense	intense	JJ	_	19	amod	_
16	public	public	JJ	p2=NN	19	amod	_
17	and	and	CC	_	16	cc	_
18	governmental	governmental	JJ	_	16	conj	_
19	scrutiny	scrutiny	NN	_	14	pobj	_
20	'	'	''	_	11	punct	_
21	and	and	CC	_	11	cc	_
22	brought	bring	VBD	p2=VBN|pb=bring.01	11	conj	_
23	'	'	``	p2=''	22	punct	_
24	increased	increase	VBN	p2=VBD|pb=increase.01	25	amod	_
25	uncertainty	uncertainty	NN	_	22	dobj	22:A1=PPT;24:A1=PPT
26	'	'	''	_	22	punct	_
27	for	for	IN	_	22	prep	22:AM-PRP
28	shareholders	shareholder	NNS	_	27	pobj	_
29	.	.	.	_	2	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	4	nsubj	4:A0=PAG
3	also	also	RB	_	4	advmod	4:AM-DIS
4	pointed	point	VBD	pb=point.01	0	root	_
5	to	to	IN	_	4	prep	4:A2=GOL
6	the	the	DT	_	7	det	_
7	fact	fact	NN	_	5	pobj	_
8	that	that	IN	_	14	complm	_
9	the	the	DT	_	10	det	_
10	majority	majority	NN	_	14	nsubj	14:A1=PPT
11	of	of	IN	_	10	prep	_
12	the	the	DT	_	13	det	_
13	offer	offer	NN	_	11	pobj	_
14	was	be	VBD	pb=be.01	7	ccomp	_
15	still	still	RB	_	14	advmod	14:AM-TMP
16	in	in	IN	_	14	prep	14:A2=PRD
17	the	the	DT	_	18	det	_
18	form	form	NN	_	16	pobj	_
19	of	of	IN	_	18	prep	_
20	shares	share	NNS	_	19	pobj	29:A1
21	-	-	:	p2=,	20	punct	_
22	which	which	WDT	_	29	dobj	29:R-A1
23	many	many	JJ	_	25	amod	_
24	Astra	astra	NNP	p2=JJ	25	nn	_
25	investors	investor	NNS	_	27	nsubj	29:A0=PAG
26	would	would	MD	_	27	aux	27:AM-MOD
27	have	have	VB	pb=have.02	20	rcmod	_
28	to	to	TO	_	29	aux	_
29	sell	sell	VB	pb=sell.01	27	xcomp	_
30	.	.	.	_	4	punct	_

1	'	'	''	p2=``	4	punct	_
2	The	the	DT	_	3	det	_
3	board	board	NN	_	4	nsubj	4:A0=PAG
4	believes	believe	VBZ	pb=believe.01	41	ccomp	41:A1=PPT
5	that	that	IN	_	35	complm	_
6	Pfizer	pfizer	NNP	_	9	poss	_
7	's	's	POS	_	6	possessive	_
8	final	final	JJ	_	9	amod	_
9	proposal	proposal	NN	_	35	nsubj	35:A1=PPT
10	,	,	,	_	9	punct	_
11	in	in	IN	_	9	prep	_
12	relation	relation	NN	_	11	pobj	_
13	to	to	IN	p2=TO	12	prep	_
14	price	price	NN	_	13	pobj	_
15	,	,	,	_	9	punct	_
16	form	form	NN	_	9	appos	_
17	of	of	IN	_	16	prep	_
18	consideration	consideration	NN	_	17	pobj	_
19	and	and	CC	_	16	cc	_
20	the	the	DT	_	23	det	_
21	four	#crd#	CD	_	23	num	_
22	particular	particular	JJ	_	23	amod	_
23	points	point	NNS	_	16	conj	25:A1=PPT
24	that	that	WDT	_	25	nsubj	25:R-A1
25	are	be	VBP	pb=be.01	23	rcmod	_
26	central	central	JJ	_	25	acomp	25:A2=PRD
27	to	to	IN	_	26	prep	_
28	the	the	DT	_	29	det	_
29	board	board	NN	_	31	poss	_
30	's	's	POS	_	29	possessive	_
31	concerns	concern	NNS	_	27	pobj	_
32	around	around	IN	_	31	prep	_
33	value	value	NN	_	32	pobj	_
34	,	,	,	_	35	punct	_
35	remains	remain	VBZ	pb=remain.01	4	ccomp	4:A1=PPT
36	inadequate	inadequate	JJ	_	35	acomp	35:A3=PRD
37	,	,	,	_	41	punct	_
38	'	'	''	_	41	punct	_
39	the	the	DT	_	40	det	_
40	firm	firm	NN	_	41	nsubj	41:A0
41	said	say	VBD	pb=say.01	0	root	_
42	.	.	.	_	41	punct	_

1	'	'	``	p2=POS	7	punct	_
2	Accordingly	accordingly	RB	_	7	advmod	7:AM-DIS
3	,	,	,	_	7	punct	_
4	the	the	DT	_	5	det	_
5	board	board	NN	_	7	nsubj	7:A0=PAG
6	has	have	VBZ	_	7	aux	_
7	rejected	reject	VBN	pb=reject.01	0	root	_
8	the	the	DT	_	10	det	_
9	final	final	JJ	_	10	amod	_
10	proposal	proposal	NN	_	7	dobj	7:A1=PPT
11	.	.	.	_	7	punct	_

1	'	'	``	p2=''	8	punct	_
2	The	the	DT	_	3	det	_
3	comments	comment	NNS	_	8	nsubjpass	8:A1=PPT
4	below	below	RB	p2=WDT	3	advmod	_
5	have	have	VBP	_	8	aux	_
6	not	not	RB	_	8	neg	8:AM-NEG
7	been	be	VBN	_	8	auxpass	_
8	moderated	moderate	VBN	pb=moderate.01	0	root	_
9	.	.	.	_	8	punct	_

1	The	the	DT	_	2	det	_
2	views	view	NNS	_	8	nsubj	3:A1=PPT;8:A1=PPT;17:A2=PAG
3	expressed	express	VBD	p2=VBN|pb=express.01	2	partmod	_
4	in	in	IN	_	3	prep	3:AM-MNR
5	the	the	DT	_	6	det	_
6	contents	content	NNS	_	4	pobj	_
7	above	above	RB	p2=IN	6	advmod	_
8	are	be	VBP	pb=be.01	0	root	_
9	those	those	DT	_	8	attr	8:A2=PRD
10	of	of	IN	_	9	prep	_
11	our	our	PRP$	_	12	poss	_
12	users	user	NNS	_	10	pobj	_
13	and	and	CC	_	8	cc	_
14	do	do	VBP	_	17	aux	_
15	not	not	RB	_	17	neg	17:AM-NEG
16	necessarily	necessarily	RB	_	17	advmod	17:AM-ADV
17	reflect	reflect	VB	pb=reflect.01	8	conj	_
18	the	the	DT	_	19	det	_
19	views	view	NNS	_	17	dobj	17:A1=PPT
20	of	of	IN	_	19	prep	_
21	MailOnline	mailonline	NNP	_	20	pobj	_
22	.	.	.	_	17	punct	_

1	We	we	PRP	_	5	nsubj	5:A0=PAG
2	are	be	VBP	_	5	aux	_
3	no	no	RB	_	4	neg	_
4	longer	long	RBR	p2=RB	5	advmod	5:AM-TMP
5	accepting	accept	VBG	pb=accept.01	0	root	_
6	comments	comment	NNS	_	5	dobj	5:A1=PPT
7	on	on	IN	_	6	prep	_
8	this	this	DT	_	9	det	_
9	article	article	NN	_	7	pobj	_
10	.	.	.	_	5	punct	_

